manzoor ahmad parry

@skims.ac.in

senior resident, department of nephrology
Sher i kashmir institute of medical sciences

manzoor ahmad parry


               Download Compact PDF  
https://researchid.co/doc_parry

EDUCATION

DM (Nephrology) from Gauhati Medical College and Hospital: Guwahati, Assam (2016-08-05 to present 2019-08-04 )

MD (internal medicine from Sher-i-Kashmir Institute of Medical Sciences: Srinagar, Jammu and Kashmir (2012-05-29 to 2015-04-28)
MBBS from Government Medical College Srinagar: Srinagar, Jammu and Kashmir, (2005-08-01 to 2011-11-30)

RESEARCH INTERESTS

Nephrology
transplantation
Dialysis
14

Scopus Publications

Scopus Publications

  • Clinical profile and outcome of primary membranous nephropathy: A tertiary care center experience from North India
    Muzamil Ahmad Wani, Imran Khan, Jawad Iqbal Rather, Mohammad Ashraf Bhat, Muzafar Maqsood Wani, Imtiyaz Ahmad Wani, Rayees Yousuf Sheikh, Manzoor Ahmad Parry
    World Journal of Nephrology, 2026
    BACKGROUND Primary membranous nephropathy (MN) is a major cause of nephrotic syndrome in adults, characterized by immune complex formation on the outer side of the glomerular basement membrane. Primary MN accounts for 80% of the cases, and 20% cases are associated with a secondary etiology. While immunosuppressive therapy has improved patient outcomes in MN, the clinical profile and treatment outcomes of MN in our patient population have not been previously studied. AIM To investigate the clinicopathological profile and outcomes of primary MN patients. We included consenting patients aged ≥ 18 years with primary MN and excluded those with end-stage kidney disease, pregnancy, or secondary MN. METHODS This study approved by the institutional ethics committee, was conducted at the Department of Nephrology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India. Detailed history, physical examination, laboratory investigations [including 24-hour urinary protein, kidney and liver function tests, and anti-phospholipase A2 receptor (PLA2R) antibody levels], and screening for secondary etiologies were performed. Renal biopsy tissues were examined using light microscopy, immunofluorescence, immunohistochemistry for PLA2R, thrombospondin type 1 domain-containing 7A, neural epidermal growth factor-like 1 (NELL-1), exostosin 1, exostosin 2, and electron microscopy. Patients were risk-stratified based on proteinuria, kidney function, and serum anti-PLA2R antibody levels. Remission, relapse, and resistant disease were defined by specific proteinuria and albumin criteria. RESULTS Of 46 patients, 60.9% were female, with a mean age of 43.8 ± 13.7 years. The mean proteinuria was 5.8 ± 3.2 g/day, mean serum albumin was 2.5 ± 0.39 g/dL, and mean estimated glomerular filtration rate was 99.8 ± 26.6 mL/minute/1.73 m2. Edema was the most common symptom (100%), and hypertension was the most frequent comorbidity (37%). Serum anti-PLA2R antibodies were positive in 39.1% of patients. On immunohistochemistry, 58.7% were tissue PLA2R positive and 17.4% were NELL-1 positive. At baseline, 71.1% of patients were in the high-risk category. Initial non-immunosuppressive supportive care was given to 84.8% of patients, with 23.08% achieving remission. Among those receiving immunosuppressive therapy, 72.2% on modified Ponticelli regimen and 85.7% on other regimens achieved remission at 6 months (P = 0.432). At 12 months, 82.9% of patients on immunosuppressive therapy achieved remission. Both modified Ponticelli and other immunosuppressive regimens significantly improved proteinuria and serum albumin at 12 months (P < 0.0001). CONCLUSION PLA2R-associated MN was the most common form of MN, followed by NELL-1. Primary MN prevalence was highest in the fifth and sixth decades of life, with a slight female preponderance observed in this study. Most patients belonged to the high-risk group. Immunosuppression led to complete remission in over 80% of patients, with no significant difference in remission rates between different immunosuppressive agents. This study provides initial insights into MN in the local patient population, despite its limitations of being a single-center observational study with a relatively small sample size and short follow-up.
  • Comparison of Taurolock solution with heparin as lock solution of tunneled catheters
    Hamad Jeelani, Manzoor Ahmad Parry, Amer Said Alameri, Dalia Moussa, Surabhi Gupta, Arasu Mohan, Ahmed Jalal, Ahmed Hassan, Peter William, Said Qader, Ibrahim Hamdi, Mohammed Shaban, Sally Samy, Gada Ibrahim, Pola Fikry
    Saudi Journal of Kidney Diseases and Transplantation, 2026
    Introduction: The employment of dialysis catheters can result in catheter-related blood stream infections (CRBSI), leads to hospitalization, morbidity, and mortality. Citrate-taurolidine lock solution can lower the occurrence of CRBSI. This study was done to evaluate Citrate-taurolidine lock solution for decreasing CRBSI. Materials and Methods: This retrospective study included 89 patients who received hemodialysis for at least 6 months via a tunneled catheter. A comparison was made between patients who were administered TauroLock-Hep500™ (taurolidine, citrate, and heparin) or heparin lock solution for catheter-related infection and catheter dysfunction. Results: In this study, 47 patients received heparin lock-solution and 42 patients received Taurolock lock-solution. During a total of 7560 catheter days, the Taurolock group experienced CRBSI in 3 patients. In contrast, the heparin group had 15 patients with CRBSI over a span of 8140 catheter days. This corresponds to an incidence rate of 0.39 episodes of CRBSI per 1000 catheter days in the Taurolock group and 1.84 episodes per 1000 catheter days in the heparin group. Catheter dysfunction rates were similar in the Taurolock group compared to the heparin lock solution. In addition, in the Heparin group, two patients necessitated catheter removal, whereas no patients in the Taurolock group required catheter removal. Conclusion: Our study demonstrates a higher incidence of CRBSI in the Heparin group compared to the Taurolock solution and a similar effectiveness of the Taurolock solution in preventing catheter dysfunction over Heparin.
  • Clinical Characteristics and Outcome of Kidney Transplant Recipients Infected with COVID-19: A Retrospective Observational Study
    Manzoor Ahmad Parry, Rayees Yousuf Sheikh, Raja Kaamil Qadri, Muzafar Maqsood Wani, Imtiyaz Wani, Mohammad Ashraf Bhat
    Indian Journal of Transplantation, 2024
    Background: This study investigated the clinical characteristics and outcomes of kidney transplant recipients (KTRs) who contracted COVID-19. Methods: In this retrospective study, we analyzed data from 122 KTRs confirmed to have COVID-19. Results: The mean age in patients with mild COVID-19 disease was 37.1 ± 9.1 years, whereas those with moderate and severe disease were 44.7 ± 13.7 and 48.1 ± 11.2 years, respectively (P = 0.02). The median neutrophil-to-lymphocyte ratio was 4.2 (interquartile range [IQR] 3.0–6.8) for mild cases, 6.5 (IQR: 5.0–10.8) for moderate cases, and 19 (IQR: 7.0–24.7) for severe cases (P = 0.008). The median C-reactive protein (CRP) levels (mg/L) were 19.5 (1QR: 5.0–156.3), 53.9 (1QR: 31.5–96.0), and 63.4 (1QR: 23.2–228) for mild, moderate, and severe cases, respectively (P = 0.006). Acute kidney injury occurred in 13.6%, 60%, and 81.57% of patients with mild, moderate, and severe cases, respectively (P = 0.004). Risk factors for a composite outcome of death and dialysis included age >50 years (odds ratio [OR]: 3.25, confidence interval [CI]: 1.25–7.7; P = 0.027), nonvaccinated status (OR 2.87, CI: 1.56–4.18; P = 0.008), graft dysfunction (OR: 2.1, CI: 1.2–5.9; P = 0.034), and CT severity index (CTSI) >13 (OR 3.3, CI: 1.5–5.9; P = 0.040). Conclusions: COVID-19 infection in KTRs is linked to a high mortality rate. Advanced age, lymphopenia, elevated CRP levels, and acute graft dysfunction are associated with disease severity. Age >50 years, nonvaccinated status, graft dysfunction, and a CTSI >13 are risk factors for the composite outcome of death and dialysis.
  • Prevalence of Hepatitis C Virus Infection and Efficacy of Sofosbuvir–Velpatasvir and Sofosbuvir–Daclatasvir Treatment Regimens in End-stage Renal Disease Patients on Maintenance Hemodialysis
    Mohammad Ashraf Bhat, Aadil Nabi Mir, Manzoor Ahmad Parry, I. Parray
    Saudi Journal of Kidney Diseases and Transplantation, 2023
    Patients with end-stage renal disease (ESRD) are at an increased risk of hepatitis C virus (HCV) infection. This study evaluated the prevalence of HCV infection in patients with ESRD on maintenance hemodialysis (MHD) and studied the effectiveness of sofosbuvir-velpatasvir and sofosbuvir-daclatasvir regimens in these patients. This study included patients with ESRD on MHD between January 2019 and December 2021 who were screened for HCV serology status. HCV-positive patients received sofosbuvir-velpatasvir or sofosbuvir-daclatasvir. Efficacy was assessed by the sustained virological response (SVR), and safety assessments included monitoring adverse events and laboratory parameters. Out of 1330 patients, 188 patients (14.1%) were positive for anti-HCV, with Genotype 1 being the most common genotype. Of these, 106 patients were included. The majority were males (61.3%), and the mean age was 48.4 years. Hypertension (45.3%) was the most common cause of renal failure, followed by diabetes (31.1%). Most patients (63.2%) were positive for HCV in the first 2 years of their dialysis treatment. Out of 106 patients, only 54 had received blood transfusions. Ninety-four (88.7%) patients received sofosbuvir-velpatasvir, whereas 12 (11.3%) received sofosbuvir-daclatasvir. SVR at 12 and 24 weeks after stopping treatment was seen in all (100%) patients. Asthenia and fatigue were the most common adverse events (11.2%). No patients reported on-treatment virologic failure or discontinuation of treatment because of adverse events. The prevalence of HCV infection in this population was 14.1%, and treatment of HCV infection using sofosbuvir-velpatasvir or sofosbuvir-daclatasvir regimens was well tolerated and effective.
  • Mucocutaneous manifestations in patients with chronic kidney disease: A cross-sectional hospital-based study from North-East India
    Hitesh Khatri, Pankaj Adhicari, M. Parry, Manjuri Sharma
    Journal of the Egyptian Women S Dermatologic Society, 2022
    Background Cutaneous manifestations in chronic kidney disease (CKD) can affect quality of life and can vary across regions, races, and nutritional status of patients. Objective To study the prevalence of mucocutaneous manifestations in patients with CKD and compare between dialysis and nondialysis patients. Patients and methods This was a cross-sectional study from North-East India. A total of 210 patients with CKD were included, with 61 patients in dialysis group and 149 in the nondialysis group. A comprehensive history, detailed examination, and all the relevant investigations were done. Results There was a male predominance in this study, and the mean age was 49.85±12.5 years. Diabetes mellitus (42.9%) was the most common cause of CKD. Cutaneous involvement was seen in 142 (67.61%) patients, with predominance in dialysis patients (60/61) (98.36%) as compared with nondialysis patients (80/149) (55.03%). Xerosis (58.09%) was the most common skin change seen in 122 patients, being more in the dialysis group as compared with the nondialysis group (73.8 vs. 51.7%; P=0.0034). This was followed by pallor (36.19%) of the skin and mucosa. Pruritus (35.23%) was seen in 74 patients, being more in dialysis patients. Cutaneous infections were seen in 57 patients. Absent lunula (14.26%) and half-and-half nail (12.85%) were the most common nail changes. Mucosal changes were seen in 28 (13.33%) patients. Hair changes were seen in 16.67% of patients, with predominant affection in dialysis patients. Conclusion Xerosis, pruritus, skin pallor, absent lunula, xerostomia, macroglossia, and infections were the most common mucocutaneous manifestations in this study. Xerosis, pruritus, absent lunula, and hair changes were more common in dialysis patients.
  • Association of Vascular Endothelial Growth Factor 936 C/T Gene Polymorphism with Renal Allograft Outcome: A Study from North India
    Aadil Wasil, Manzoor Parry, Abdul Reshi, Roohi Rasool, Imtiyaz Rashid, Imtiyaz Wani
    Saudi Journal of Kidney Diseases and Transplantation, 2022
    The significance of vascular endothelial growth factor (VEGF) and its polymorphisms in renal allograft rejection has recently become the subject of extensive research. Recently, some studies have shown some role of VEGF in rejection episodes and graft survival. VEGF +936 C>T polymorphism is significant in the transcription regulation of VEGF. Herein, we report the results of a prospective, single-center study seeking an association of VEGF +936 C/T gene polymorphism and allograft rejection. One hundred and forty-seven kidney transplant recipients with age-and sex-matched controls were included in this study. VEGF 936 C/T genes were studied using restriction fragment length polymorphism analysis of the blood specimen of these patients. All patients were studied for allograft rejection, response to treatment, and overall graft survival. We found that CT genotype and T allele carrier state were associated with good graft outcomes (P = 0.008 and 0.002, respectively). There was a lower number of rejection episodes with T allele, although it was not a significant finding (P = 0.880). Our findings suggest that good graft outcome in kidney transplant recipients is associated with an increased frequency of the VEGF 936 CT genotype and T allele, and that determination of the T allele might be helpful for the identification of recipients with overall good graft survival.
  • Idiopathic Nonlupus Full-House Nephropathy: Clinicopathological Presentation and Comparison with Lupus Full-House Nephropathy
    P. Mahanta, S. Alam, M. Parry, Manjuri Sharma, P. Doley, G. Pegu, Mastakim Ahmad Mazumder, H. Jeelani, Gayatari Pegu
    Saudi Journal of Kidney Diseases and Transplantation, 2022
    Full-house pattern on immunofluorescence (IF) on kidney biopsy in a patient without systemic lupus erythematosus is termed as nonlupus full-house nephropathy (FHN). In this study, we retrospectively compiled patients with nonlupus FHN and compared them with lupus FHN for clinicopathological presentation. We included patients with full-house IF patterns in renal biopsies collected from March 2007 to August 2018, clinical and histopathological data at the time of presentation were studied retrospectively. Treatment received and outcome at the end of follow-up was studied. Patients with nonlupus FHN who did not show any systemic disease (idiopathic group) were compared with a group of lupus nephritis patients. Of 178 patients, 34 had nonlupus FHN with 21 having idiopathic nonlupus FHN and 13 patients having secondary nonlupus FHN (membranous nephropathy, IgA nephropathy, postinfection glomerulonephritis). Males were more often in idiopathic nonlupus FHN patients than lupus FHN patients (P = 0.005). Kidney biopsies more often showed a mesangial (P = 0.0006) and less proliferative pattern of injury (P = 0.0002) and less intense C1q staining (P = 0.0001) in idiopathic nonlupus than lupus FHN. Clinically, idiopathic nonlupus FHN presented with more proteinuria (P = 0.0059) and less complement consumption (P = 0.001) than lupus FHN patients. Compared to lupus FHN, nonlupus has mainly nephrotic syndrome as clinical presentation. There was no difference in the clinical outcome between lupus FHN and idiopathic nonlupus FHN. Nonlupus FHN is not a very common condition and has less female involvement than in lupus FHN. Idiopathic nonlupus FHN has certain histopathological features with less C1q staining by IF, less frequent proliferative lesions and higher mesangial or membranous lesions by light microscopy compared to lupus FHN. Regarding outcomes, there is no significant difference between lupus FHN and idiopathic nonlupus FHN.
  • Histological patterns of renal diseases in children: A 12-year experience from a single Tertiary Care Center in North-East India
    MastakimAhmed Mazumder, Manjuri Sharma, PranabJyoti Mahanta, ProdipKumar Doley, Gaytri Pegu, Shahzad Alam, ManzoorAhmad Parry, Hamad Jeelani
    Saudi Journal of Kidney Diseases and Transplantation, 2021
    This study was conducted to retrospectively investigate the indications for renal biopsy in the native kidneys of children and to analyze the pathological findings in a single tertiary care hospital in North-East India for the past 12 years. All children (≤18 years) who underwent renal biopsy at our hospital from March 2007 to April 2018 were included. Renal tissue specimens were studied under light and immunofluorescence microscopy. The study group included 254 patients (female 57%). The median age was 15 years (range 6–18 years). The most frequent indications for renal biopsy were nephrotic syndrome (NS) (53.9%), urinary abnormality in systemic disease (22.1%), nephritic syndrome (15.4%), asymptomatic hematuria (4.7%), significant proteinuria (3.1%), and unexplained renal failure (0.8%). On histopathological examination, primary glomerular diseases were the most frequent (68.9%) followed by secondary glomerular diseases (30.3%) and tubulointerstitial diseases (0.8%). The most common primary glomerular diseases were minimal change disease (26.8%), focal segmental glomerular sclerosis (12.2%), diffuse proliferative glomerulonephritis (9.1%), membranous nephropathy (8.7%), IgA nephropathy (8.3%), membranoproliferative glomerulonephritis (2%), and mesangioproliferative glomerulonephritis (2%). Lupus nephritis (LN) (29.5%) was the most common secondary glomerular disease. NS was the most common indication of renal biopsy, and LN was the most common histopathological diagnosis in children ≤18 years.
  • A comparable study on the outcomes of urgent initiated peritoneal dialysis versus conventional start, a single centre study from north-east India
    Iranian Journal of Kidney Diseases, 2020
  • Prevalence of Nondiabetic Renal Disease in Patients with Type 2 Diabetes Mellitus with Clinicopathological Correlation: A Study from a Tertiary Care Center of Assam, India
    ManzoorAhmad Parry, Manjuri Sharma, Hamad Jeelani, PranabJyoti Mahanta, ProdipKumar Doley, Gayatri Pegu
    Saudi Journal of Kidney Diseases and Transplantation, 2020
    Diabetes mellitus is the most common cause of chronic kidney disease worldwide. The prevalence of nondiabetic renal disease (NDRD) among patients with type 2 diabetes mellitus (T2DM) varies widely. This study aimed to evaluate the renal biopsies performed on type 2 diabetic patients for suspicion of NDRD and to correlate clinicopathological findings. All T2DM patients aged > 18 years were included in this study, who had renal biopsy performed for the following reasons: recent-onset nephrotic syndrome, unexplained rapid deterioration of renal function, proteinuria not accompanied by retinopathy, and unexplained hematuria. Renal biopsy was analyzed by light microscopy and immunofluorescence. Based on biopsy findings, the patients were grouped into three: (i) isolated NDRD, (ii) NDRD ± diabetic nephropathy (DN), and (iii) isolated DN. A total of 140 patients were enrolled in this study. Recent-onset nephrotic syndrome was the most common indication for biopsy, followed by the presence of active urine sediment. Forty-two percent of the patients had isolated DN, while NDRD was seen in 34% and DN ± NDRD in 24%. Focal segmental glomerulosclerosis (FSGS) and IgA nephropathy were the most common causes of isolated NDRD, while chronic tubulointerstitial nephritis (CTIN) was common in NDRD plus DN. Short duration of diabetes, absence of diabetic retinopathy, and lower glycated hemoglobin were predictive of NDRD. NDRD was seen in 58% of the patients with atypical presentations. FSGS and CTIN were common in NDRD diseases. Judicious use of biopsy in diabetic patients with atypical presentation may help in the diagnosis of NDRD.
  • Association of forkhead box P3 gene polymorphisms with allograft rejection episodes in kidney transplant patients a study from Kashmir, North India
    Iranian Journal of Kidney Diseases, 2018
  • Association of IL1 beta gene polymorphism and allograft functions in renal transplant recipients:a case control study from Kashmir Valley
    Mohammad Ashraf Bhat, Manzoor Ahmad Parry, Saniya Nissar, Aga Syed Sameer, Imtiyaz A. Bhat, Zafar A. Shah, Roohi Rasool
    BMC Nephrology, 2017
  • Aluminium phosphide poisoning with severe cardiac dysfunction and the role of digoxin
    Khalid Hamid Changal, Muzamil Latief, Manzoor Parry, Farhat Abbas
    BMJ Case Reports, 2017
  • Prevalence of dyslipidemia in school children of Kashmir valley
    Irshad Ahmad Parray, Manzoor Ahmad Parry, Muzamil latief
    Diabetes and Metabolic Syndrome Clinical Research and Reviews, 2016

RESEARCH OUTPUTS (PATENTS, SOFTWARE, PUBLICATIONS, PRODUCTS)

PUBLICATIONS
1. Bhat MA, Parry MA, Nissar S, et al. Association of IL1 beta gene polymorphism and allograft functions in renal transplant recipients :a case control study from Kashmir Valley. BMC Nephrology. 2017;18:111. doi:10.1186/s12882-017-0526-5

2. Irshad Ahmad Parray, Manzoor Ahmad Parry, Muzamil latief “Prevalence of dyslipidemia in school children of Kashmir valley” Diabetes & Metabolic Syndrome: Clinical Research & Review

3. Latief M, Abbas F, Minhas A, Dar W, Parry M, Gupta PD. Vitamin D Defciency in Rheumatoid Arthritisand Vitamin D Levels that vary with Rheumatoid Arthritis Severity:An Indian Study. J Postgrad Med Edu Res 2017;51(4):162-165.

4. NajeebUllah Sofi, Waseem Raja , Imtiyaz Ahmad Dar, Basharat Kasana, MuzamilLatief, Faheem Arshad, Moomin Hussain, Hakim Irfan, Manzoor Parray, Khurshid Iqbal “Role of thiamine supplementation in patients with heart failure – An Indian perspective” 1561-8811/# 2015 Indian College of Cardiology

5. Khalid Hamid Changal, Hameed Raina, Manzoor Ahmed Parray. Fayaz Ahmad Sofi ‘’Carcinoma of the breast presenting as deep vein thrombosis of the axillary vein’’ Caspian J Intern Med. 2013 Autumn; 4(4): 790–792.

6. Khalid Hamid Changal , Ab. Hameed Raina , Manzoor Ahmad Parray , Mohammed Sultan Allai ‘’Attempted Suicidal hanging leading to Hypoxic Ischemic Encephalopathy’’Int J Med Health Sci. July 2013,Vol-2;Issue-3

7. Yasir Bashir , Nusrat Bashir , SajadGeelani , Asif Ahmed, Manzoor Parry , Shabeer Ahmad , JavidRasool ‘’Hyperphagia- A Rare Clinical Presentation of Acute Lymphoblastic Leukemia Relapse’’ American Journal of Medical Case Reports, 2014, Vol. 2, No. 11, 247-249

8. Muzamil Latief, waseem Raja, Manzoor Parry, Ravi Rao “Scleral and Body Hyperpigmentation in Disseminated Tuberculosis with Adrenal Insufficiency (Addison’s Disease)” J Gen Practice 2016, 4:2

9. Farhat Abbas, Waseem Raja Dar,Muzamil Latief, Summyia Farooq, Manzoor Ahmad Parry, Peerzada Ziaul haq and Imtiyaz Dar “Gastrointestinal Stromal Tumors: A Review” J MolImag Dynamic 6: 124. doi:10.4172/2155-9937.1000124

10. Dar WR, Latief M, Sofi N, Dar I, Parray M, et al. (2015) A Rare Presentation of Primary Sjogrens Syndrome. J Gen Practice 3: 210. doi: 10.4172/2329-9126.1000210

11. Khuja Z, Parry M, Rasool R, Reshi AR. Association of Forkhead Box P3 Gene Polymorphisms With Allograft Rejection Episodes in Kidney Transplant Patients: a Study From Kashmir, North India. Iran J Kidney Dis. 2018 Oct;12(5):305-311

12. Sharma, M., Parry, M., Jeelani, H., & Mahanta, P. J. (2019). RETROSPECTIVE STUDY OF HISTOLOGICAL ANALYSIS AND ITS CORRELATION WITH CLINICAL PRESENTATION AND OUTCOME OF IGA NEPHROPATHY FROM A TERTIARY CENTRE OF GUWAHATI ASSAM. International Journal of Medical and Biomedical Studies, 3(2).

13. Jeelani, H., Parry, M., Dange, S. (2019). PREVALENCE OF DEPRESSION AND ITS ASSOCIATED FACTORS AMONG PATIENTS OF CHRONIC KIDNEY DISEASE IN A TERTIARY CARE HOSPITAL FROM ASSAM: A CROSS-SECTIONAL STUDY. International Journal of Medical and Biomedical Studies, 3,(11) 95-102

14. Mastakim A Mazumder, Manzoor A Parry, Hamad Jeelani, Shahzad Alam. A Comparative Study of Newer and Conventional Risk Factors of Coronary Artery Disease in Young Patients: A Case-Control Study from a Centre in Uttar Pradesh, India. Int J Med Res Prof. 2018 Nov; 4(6):109-13. DOI:10.21276/


15. Sharma M, Parry MA, Mahanta PJ, Doley P, Pegu G, Jeelani H. Drug-induced Acute Kidney Injury/ Acute Tubulointerstitial Nephritis: A Clinico-etiological Study from a Single Center in North-east India. Journal of Postgraduate Medicine, Education and Research, Jan-Mar 2019;53(1):00-00.

16. Jeelani, H., Sharma, M., Parry, M. A., Doley, P., & Pegu, G. (2019). PULMONARY HYPERTENSION IN END STAGE KIDNEY DISEASE (ESKD) PATIENTS ON MAINTENANCE HEMODIALYSIS (MHD) VIA SURGICALLY CREATED ARTERIOVENOUS FISTULA. International Journal of Medical and Biomedical Studies, 3(11).